Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors

Contributed by: GlobeNewswire

Tags

Appointment new Chair

More Like This

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer

Anaveon Appoints Laetitia Pouzol as Chief Scientific Officer

Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio

Mestag Therapeutics Appoints Dr. Matthew Sleeman as Chief Scientific Officer

RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors

Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio

EGLE Therapeutics Strengthens its Board of Directors with the Appointment of Michel Detheux, Ph.D., as Independent Chairman Board Member, and with the Appointment of Mojgan Hossein-Nia, Ph.D. as Board Member Representative of Takeda Ventures